Treatment with the cannabis-based oral spray Nabiximols has been found to significantly relieve spasticity, a common symptom of multiple sclerosis (MS), according to a new analysis of two MS clinical trials.
Spasticity is characterized by increased muscle stiffness and spasms, which can be uncomfortable and hinder movement.
Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio. Sign up now:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
